Cargando…

Serological biomarkers for management of primary sclerosing cholangitis

Clinical manifestations and progression of primary sclerosing cholangitis (PSC) are heterogeneous, and its pathogenesis is poorly understood. The importance of gut-liver interactions in the pathogenesis has been clinically confirmed and highlighted in different theories. Recent advances regarding bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tornai, David, Ven, Peter Laszlo, Lakatos, Peter Laszlo, Papp, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185217/ https://www.ncbi.nlm.nih.gov/pubmed/35800183 http://dx.doi.org/10.3748/wjg.v28.i21.2291

Ejemplares similares

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2017)

Role of endoscopy in the management of primary sclerosing cholangitis
por: Marya, Neil Bharat, et al.
Publicado: (2019)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
por: Tornai, Tamas, et al.
Publicado: (2018)

Gut microbiome in primary sclerosing cholangitis: A review
por: Little, Rebecca, et al.
Publicado: (2020)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
por: Fung, Brian M, et al.
Publicado: (2019)

Noninvasive prognostic models, imaging, and elastography to predict clinical events in primary sclerosing cholangitis: A review
por: Russo, Mark W
Publicado: (2023)

Small duct primary sclerosing cholangitis: A discrete variant or a bridge to large duct disease, a practical review
por: Nguyen, Christopher M, et al.
Publicado: (2022)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

Pathogenesis of primary sclerosing cholangitis
por: Pollheimer, Marion J., et al.
Publicado: (2011)

Osteoporosis in primary biliary cholangitis
por: Danford, Christopher J, et al.
Publicado: (2018)

Primary sclerosing cholangitis.
por: Spence, R. A., et al.
Publicado: (1984)

Primary sclerosing cholangitis
por: Worthington, Joy, et al.
Publicado: (2006)

IgG4-Related Sclerosing Cholangitis and Primary Sclerosing Cholangitis
por: Tanaka, Atsushi
Publicado: (2019)

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
por: Gauss, Annika, et al.
Publicado: (2016)

Primary sclerosing cholangitis: diagnostic and management challenges
por: Sirpal, Sanjeev, et al.
Publicado: (2017)

Sequence of events leading to primary biliary cholangitis
por: Lenci, Ilaria, et al.
Publicado: (2023)

The immunobiology of primary sclerosing cholangitis
por: Aron, Jonathan H., et al.
Publicado: (2009)

Primary sclerosing cholangitis and pregnancy
por: Kammeijer, Casper Q., et al.
Publicado: (2011)

An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?
por: Fickert, Peter, et al.
Publicado: (2007)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis
por: Mindikoglu, Ayse L, et al.
Publicado: (2019)

Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management
por: Kumar, Aditi, et al.
Publicado: (2016)

Understanding fatigue in primary biliary cholangitis: From pathophysiology to treatment perspectives
por: Lynch, Erica Nicola, et al.
Publicado: (2022)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Treatment of primary sclerosing cholangitis in children
por: Laborda, Trevor J, et al.
Publicado: (2019)

Diagnosing Primary Sclerosing Cholangitis in Children
por: Seerat, Iqtadar, et al.
Publicado: (2020)

Role of Endoscopy in Primary Sclerosing Cholangitis
por: Bhat, Purnima, et al.
Publicado: (2021)

Current Therapeutics in Primary Sclerosing Cholangitis
por: Tan, Natassia, et al.
Publicado: (2023)

Primary sclerosing cholangitis and the path to translation
por: Váncza, Lóránd, et al.
Publicado: (2023)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Acute cholangitis - an update
por: Ahmed, Monjur
Publicado: (2018)

An overview of recent treatment options for primary sclerosing cholangitis
por: Mousavere, Ioanna, et al.
Publicado: (2023)

The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia
por: Lopens, Steffi, et al.
Publicado: (2020)

Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
por: Fung, Brian M., et al.
Publicado: (2019)

Management of primary sclerosing cholangitis and its complications: an algorithmic approach
por: Prokopič, Michal, et al.
Publicado: (2020)

Long-Term Follow-Up into Adulthood of Pediatric-Onset Primary Sclerosing Cholangitis and Autoimmune Sclerosing Cholangitis
por: Hercun, Julian, et al.
Publicado: (2022)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
por: Banales, Jesus M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_04h6dv8e0tl9uqk8hebeg84jto